05.08.2008 ACADIA Pharmaceuticals Announces Second Quarter 2008 Financial Results and Strategic Restructuring

31.07.2008 MediGene Sells Licensee Rights to the Drug Oracea® to Galderma

28.04.2008 NuSep Interest Bearing 14% Converting Notes

28.03.2008 Merck Shareholders Approve Record Dividend of EUR 1.20/Share plus Bonus of EUR 2.00/Share During AGM

27.03.2008 MOLOGEN AG announces results for financial year 2007

26.03.2008 DAIICHI SANKYO Extends Alliance with MorphoSys for Use of HuCAL GOLD to Develop Novel Antibody Therapies

05.03.2008 Kyowa Hakko and Amgen Enter Licensing Agreement for Anti-CCR4 Humanized Monoclonal Antibody

05.03.2008 AbD Serotec Receives Large Research Antibody Order from Proteomics Specialist Proteomika

29.02.2008 Solvay Pharmaceuticals S.A. acknowledges decision of Wyeth Pharmaceuticals to terminate the collaboration agreement on bifeprunox

21.02.2008 MorphoSys and Astellas Extend Alliance for Use of HuCAL GOLD to Develop Novel Antibody Therapies

19.02.2008 Pharmion Corporation Announces 2007 Operating Results

04.02.2008 Amgen and Takeda Announce Exclusive Collaboration in Japan on up to 13 Amgen Clinical Candidates

21.12.2007 Lundbeck expands agreement with PAION for desmoteplase

04.12.2007 PregLem SA announces CHF 36 Million Series B funding and new licencing agreement with HRA Pharma

04.12.2007 Tripep raises SEK 24 million through a rights issue